Cancer pain: where are we now?

被引：49
|
作者：
Magee, David [1 ]
Bachtold, Sabina [1 ]
Brown, Matthew [1 ,2 ]
Farquhar-Smith, Paul [1 ]
机构：
[1] Royal Marsden Hosp, Dept Pain Med, Fulham Rd, London SW3 6JJ, England
[2] Inst Canc Res, Targeted Approaches Canc Pain Grp, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England
来源：
PAIN MANAGEMENT | 2019年 / 9卷 / 01期
关键词：
cancer pain; large-scale data; pain assessment; pain management; recent advances; PERIPHERAL NEUROPATHIC PAIN; INDUCED ORAL MUCOSITIS; PERSISTENT POSTSURGICAL PAIN; INHIBITOR-INDUCED ARTHRALGIA; EARLY PALLIATIVE CARE; QUALITY-OF-LIFE; BREAST-CANCER; RADIATION-THERAPY; DOUBLE-BLIND; NERVE DAMAGE;
D O I：
10.2217/pmt-2018-0031
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Increasing numbers of those living with and beyond cancer presents a clinical challenge for pain specialists. A large proportion of these patients experience pain secondary to their disease or its treatment, impeding rehabilitation and significantly impacting upon their quality of life. The successful management of this pain presents a considerable challenge. This review aims to outline current concepts and treatment options, while considering nuances within pain assessment and the use of large-scale data to help guide further advances.
引用
收藏
页码：63 / 79
页数：17
相关论文
共 50 条
  • [31] Tocolysis for Acute Preterm Labor: Where Have We Been, Where Are We Now, and Where are We Going?
    Navathe, Reshama
    Berghella, Vincenzo
    AMERICAN JOURNAL OF PERINATOLOGY, 2016, 33 (03) : 229 - 235
  • [32] Accelerated Partial Breast Irradiation (APBI): Where Are We Now?
    Goldberg, Mira
    Whelan, Timothy J.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (04) : 275 - 284
  • [33] Chemotherapy-induced peripheral neuropathy: where are we now?
    Colvin, Lesley A.
    PAIN, 2019, 160 : S1 - S10
  • [34] Menopausal hot flushes and night sweats: where are we now?
    Archer, D. F.
    Sturdee, D. W.
    Baber, R.
    de Villiers, T. J.
    Pines, A.
    Freedman, R. R.
    Gompel, A.
    Hickey, M.
    Hunter, M. S.
    Lobo, R. A.
    Lumsden, M. A.
    MacLennan, A. H.
    Maki, P.
    Palacios, S.
    Shah, D.
    Villaseca, P.
    Warren, M.
    CLIMACTERIC, 2011, 14 (05) : 515 - 528
  • [35] Extended endocrine therapy in premenopausal breast cancer patients: Where are we now?
    Villasco, Andrea
    D'Alonzo, Marta
    BREAST JOURNAL, 2020, 26 (10) : 2018 - 2020
  • [36] Resection of primary lesion for patients with metastatic breast cancer: where are we now?
    Hu, Qiancheng
    Zhong, Xiaorong
    Liu, Xu
    Xie, Yuxin
    Hu, Kejia
    He, Ping
    Lu, Donghao
    Zheng, Hong
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [37] Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
    Machado, Vera
    Morais, Mariana
    Medeiros, Rui
    PHARMACEUTICS, 2022, 14 (10)
  • [38] Perspectives on irritable bowel syndrome: where have we been? Where are we now?
    Stanghellini, Vincenzo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (05) : 3 - 7
  • [39] Anti-cocaine Vaccine Development: Where Are We Now and Where Are We Going?
    Stephenson, Rachel J. J.
    Toth, Istvan
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (11) : 7086 - 7100
  • [40] Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
    Zeng, Huihua
    Liu, Fen
    Zhou, Hairong
    Zeng, Changchun
    FRONTIERS IN ONCOLOGY, 2021, 11
12345